Systemic immune-inflammation index and other inflammatory parameters in patients receiving biological or targeted synthetic DMARDs for inflammatory rheumatic disease
Objective: To investigate the short – and long-term dynamics in inflammation markers [systemic immune-inflammation index (SII), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and lymphocyte/ monocyte ratio (LMR)] before and after biological disease-modifying antirheumatic drugs (bDMARD) or targeted synthetic DMARD (tsDMARD) treatment. Patients and Methods: Two hundred twenty-six patients (115 women, 47±13.8 years) were included. Age, gender, disease duration, and treatments were recorded retrospectively. Complete blood counts including neutrophil, lymphocyte, platelet, monocyte and acute phase reactants were noted at the visit before the biological treatment, at the 3rd month, 6th month, and the last visit on medication. SII, NLR, PLR and LMR were calculated, and their dynamics over time were compared. Results: Significant changes were observed over time in all parameters reflecting inflammation (SII, NLR, PLR, LMR, ESR, and CRP) (p<0.05). In the correlation analysis of changes at baseline and six months, significant correlations with ΔESR were observed with ΔCRP, ΔPLR, ΔSII and ΔNLR (p<0.05), but no correlation with LMR was detected. Also, significant correlations with ΔCRP were noted with ΔNLR, ΔSII, ΔPLR, and ΔLMR (p<0.05). Conclusion: Significant and favourable changes were observed in all inflammatory parameters after treatment, and this variation remained stable as long as the drug was continued.
___
- Kim MJ, Lee EB, Song YW, Park JK. Profile of common
inflammatory markers in treatment-naïve patients with
systemic rheumatic diseases. Clin Rheumatol 2020;39:2899-
906.doi:10.1007/s10067.020.05049-9
- Kadiyoran C, Zengin O, Cizmecioglu HA, et al. Monocyte
to lymphocyte ratio, Neutrophil to lymphocyte ratio, and
red cell distribution width are the associates with gouty
arthritis. Acta Medica (Hradec Kralove)
- Gasparyan AY, Ayvazyan L, Mukanova U, et al. The plateletto-
lymphocyte ratio as an inflammatory marker in rheumatic
diseases. Ann Lab Med 2019;39:345-57.doi:10.3343/
alm.2019.39.4.345
- Walzik D, Joisten N, Zacher J, Zimmer P. Transferring
clinically established immune inflammation markers into
exercise physiology: focus on neutrophil-to-lymphocyte
ratio, platelet-to-lymphocyte ratio and systemic immuneinflammation
index. Eur J Appl Physiol 2021;121:1803-14.
doi:10.1007/s00421.021.04668-7
- Hemond CC, Glanz BI, Bakshi R, Chitnis T, Healy BC. The
neutrophil-to-lymphocyte and monocyte-to-lymphocyte
ratios are independently associated with neurological
disability and brain atrophy in multiple sclerosis. BMC Neurol
2019;19:23.doi:10.1186/s12883.019.1245-2
- Han BK, Wysham KD, Cain KC, Tyden H, Bengtsson AA,
Lood C. Neutrophil and lymphocyte counts are associated with
different immunopathologiceal mechanisms in systemic lupus
erythematosus. Lupus Sci Med 2020;7: e000382.doi:10.1136/
- Hoffmann JHO, Knoop C, Enk A, Hadaschik EN. Detailed
Long-term dynamics of neutrophil-to-lymphocyte ratio
under biologic treatment reveals differential effects of tumour
necrosis factor-alpha and interleukin 12/23 antagonists.
Acta Derm Venereol 2021;101:adv00568.doi:10.2340/actadv.
v101.271
- An I, Ucmak D, Ozturk M. The effect of biological agent
treatment on neutrophil-to-lymphocyte ratio, platelet-tolymphocyte
ratio, mean platelet volume, and C-reactive
protein in psoriasis patients. Postepy Dermatol Alergol
2020;37:202-6.doi:10.5114/ada.2020.94838
- Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte
ratio better predicts inflammation than neutrophil-tolymphocyte
ratio in end-stage renal disease patients. Hemodial
Int 2013;17:391-6.doi:10.1111/hdi.12040
- Geng Y, Shao Y, Zhu D, et al. Systemic immune-inflammation
index predicts prognosis of patients with esophageal squamous
cell carcinoma: a propensity score-matched analysis. Sci Rep
2016;6:39482.doi:10.1038/srep39482
- Strand V, Kimberly R, Isaacs JD. Biologic therapies in
rheumatology: lessons learned, future directions. Nat Rev
Drug Discov 2007;6:75-92.doi:10.1038/nrd2196
- Boyle DL, Soma K, Hodge J, et al. The JAK inhibitor tofacitinib
suppresses synovial JAK1-STAT signalling in rheumatoid
arthritis. Ann Rheum Dis 2015;74:1311-6.doi:10.1136/
annrheumdis-2014-206028
- Zahorec R. Neutrophil-to-lymphocyte ratio, past, present
and future perspectives. Bratisl Lek Listy 2021;122:474-88.
doi:10.4149/BLL_2021_078
- Yorulmaz A, Hayran Y, Akpinar U, Yalcin B. Systemic
immune-inflammation index (SII) predicts increased
severity in psoriasis and psoriatic arthritis. Curr Health Sci J
2020;46:352-7.doi:10.12865/CHSJ.46.04.05
- Dayer E, Dayer JM, Roux-Lombard P. Primer: the practical
use of biological markers of rheumatic and systemic
inflammatory diseases. Nat Clin Pract Rheumatol 2007;3:512-
20.doi:10.1038/ncprheum0572.
- Ahn SS, Jung SM, Song JJ, Park YB, Lee SW. Neutrophil to
lymphocyte ratio at diagnosis can estimate vasculitis activity
and poor prognosis in patients with ANCA-associated
vasculitis: a retrospective study. BMC Nephrol 2018;19:187.
doi:10.1186/s12882.018.0992-4
- Uslu AU, Küçük A, Şahin A, et al. Two new inflammatory
markers associated with Disease Activity Score-28 in patients
with rheumatoid arthritis: neutrophil-lymphocyte ratio and
platelet-lymphocyte ratio. Int J Rheum Dis 2015;18:731-5.
doi:10.1111/1756-185X.12582
- Kim S, Eliot M, Koestler DC, Wu WC, Kelsey KT. Association
of neutrophil-to-lymphocyte ratio with mortality and
cardiovascular disease in the jackson heart study and
modification by the duffy antigen variant. JAMA Cardiol
2018;3:455-62. doi:10.1001/jamacardio.2018.1042
- Walvick MD, Walvick MP. Giant cell arteritis: laboratory
predictors of a positive temporal artery biopsy. Ophthalmology
2011;118:1201-4.doi:10.1016/j.ophtha.2010.10.002
- Oh LJ, Wong E, Andrici J, McCluskey P, Smith JEH, Gill AJ.
Full blood count as an ancillary test to support the diagnosis of
giant cell arteritis. Intern Med J 2018;48:408-13. doi:10.1111/
imj.13713
- Zhang Y, Yin Y, Kuai S-g, Shan Z, Pei H, Wang J. Combination
of neutrophil to lymphocyte ratio and platelet to lymphocyte
ratio as diagnostic biomarker for rheumatoid arthritis. Int J
Clin Exp Med 2016;9:22076-22081
- Sargin G, Senturk T, Yavasoglu I, Kose R. Relationship between
neutrophil-lymphocyte, platelet-lymphocyte ratio and disease
activity in rheumatoid arthritis treated with rituximab. Int J
Rheum Dis 2018;21:2122-7.doi:10.1111/1756-185X.13400
- Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa
H. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio
and mean platelet volume in Japanese patients with psoriasis
and psoriatic arthritis: Response to therapy with biologics. J
Dermatol 2017;44:1112-21.doi:10.1111/1346-8138.13875
- Qian H, Chen R, Wang B, et al. Associations of platelet
count with inflammation and response to anti-tnf-α therapy
in patients with ankylosing spondylitis. Front Pharmacol
2020;11:559593.doi:10.3389/fphar.2020.559593
- Boyraz I, Koç B, Boyacı A, Tutoğlu A, Sarman H, Ozkan H.
Ratio of neutrophil/lymphocyte and platelet/lymphocyte in
patient with ankylosing spondylitis that are treating with anti-
TNF. Int J Clin Exp Med 2014;7:2912-5.
- Li C, Tian W, Zhao F, et al. Systemic immune-inflammation
index, SII, for prognosis of elderly patients with newly
diagnosed tumors. Oncotarget 2018;9:35293-9.doi:10.18632/
oncotarget.24293
- Satis S. New inflammatory marker associated with disease
activity in rheumatoid arthritis: the systemic immuneinflammation
index. Curr Health Sci J 2021;47:553-7.
doi:10.12865/CHSJ.47.04.11
- Kim JW, Jung JY, Suh CH, Kim HA. Systemic immuneinflammation
index combined with ferritin can serve as a
reliable assessment score for adult-onset Still’s disease. Clin
Rheumatol 2021;40:661-8. doi:10.1007/s10067.020.05266-2
- Chen JB, Tang R, Zhong Y, et al. Systemic immuneinflammation
index predicts a reduced risk of end-stage
renal disease in Chinese patients with myeloperoxidase-antineutrophil
cytoplasmic antibody-associated vasculitis: A
retrospective observational study. Exp Ther Med 2021;22:989.
doi:10.3892/etm.2021.10421
- Tanacan E, Dincer D, Erdogan FG, Gurler A. A cutoff value
for the Systemic Immune-Inflammation Index in determining
activity of Behçet disease. Clin Exp Dermatol 2021;46:286-91.
doi:10.1111/ced.14432